US stocks retreated Friday after President Trump threatened Canada with a 35% tariff on its imports to the US and floated ...

Fitch expects Renesas’ profitability to recover gradually, with a mid-single digit revenue decline in 2025, followed by moderate recovery in 2026-2027. Higher R&D expenses are expected to lower the ...

The company disclosed that despite confidential discussions with potential new and existing investors, no financing transaction has materialized. Karyopharm’s board is now evaluating strategic ...

Team Dow remains agile and focused on taking proactive actions to improve profitability in the midst of persistent ...